Alkem Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹3,603.32 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.57 per cent from ₹3,736.82 crore. This corresponds to a year-on-year *(YoY) growth of 14.62 per cent.
Operating Profit
Operating Profit stands at ₹382.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 50.67 per cent from ₹775.21 crore. This corresponds to a year-on-year *(YoY) decline of 2.27 per cent.
PBDT
PBDT stands at ₹528.04 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 39.70 per cent from ₹875.71 crore. This corresponds to a year-on-year *(YoY) growth of 3.90 per cent.
Profit Before Tax
Profit Before Tax stands at ₹422.28 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 45.91 per cent from ₹780.70 crore. This corresponds to a year-on-year *(YoY) growth of 6.71 per cent.
Net Profit
Net Profit stands at ₹251.11 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 61.55 per cent from ₹653.03 crore. This represents a 22.11 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Alkem Laboratories Ltd News
Alkem Laboratories Ltd Earnings
- YOY
- QOQ
Alkem Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Alkem Laboratories Ltd Research Reports
Alkem Laboratories Ltd Financial Reports
Alkem Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Alkem Lab | 0.79% | -1.24% | -3.80% | -0.55% | -0.41% | 1.74% |
| Aurobindo Pharma | -1.20% | -0.24% | 4.97% | 9.08% | 41.24% | 50.28% |
| Biocon | -1.01% | -4.49% | -5.86% | -3.63% | 8.42% | 12.77% |
| Glenmark Pharma. | -0.73% | 1.44% | 3.75% | -0.75% | 14.47% | 17.66% |
| Abbott India | -1.10% | -4.39% | -5.29% | -4.11% | 1.18% | -17.92% |
| Anthem Bioscienc | 0.87% | 0.70% | 13.45% | 13.68% | 30.62% | 12.14% |
| Gland Pharma | 0.11% | 1.63% | 20.84% | 37.64% | 60.91% | 50.74% |
Company Info
Company Information
Executive Chairman : Basudeo N Singh
Managing Director : SANDEEP SINGH
Executive Director : Mritunjay Kumar Singh
Company Sec. & Compli. Officer : Manish Narang
Independent Director : Narendra Aneja
Executive Director : SARVESH SINGH
Executive Director : Madhurima Singh
Independent Director : Sujjain Talwar
Executive Director : Srinivas Singh
Independent Director : Rajeev Kher
Independent Director : Ranjal Laxmana Shenoy
Independent Director : Neela Bhattacherjee
Independent Director : Diwakar Gupta